Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies.

× No keyword cloud information.

6 in total

1. The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.

Authors: Bagirath Gangadharan; Mathieu Ing; Sandrine Delignat; Ivan Peyron; Maud Teyssandier; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal: Haematologica Date: 2016-10-06 Impact factor: 9.941

2. Impact of the Survey of Inhibitors in Plasma-Product Exposed Toddlers (SIPPET) study and its post hoc analyses on clinical practice in the United States: A survey of Haemophilia and Thrombosis Research Society members.

Authors: Christopher M Sande; Ahmad Al-Huniti; Patrick Ten Eyck; Anjali A Sharathkumar
Journal: Haemophilia Date: 2019-07-02 Impact factor: 4.287

3. Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Authors: Jerry S Powell
Journal: Ther Clin Risk Manag Date: 2009-05-20 Impact factor: 2.423

4. Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.

Authors: Min Xuan; Feng Xue; Rongfeng Fu; Yanhui Yang; Lei Zhang; Mengsu Tian; Renchi Yang
Journal: J Thromb Thrombolysis Date: 2014-07 Impact factor: 2.300

5. A role for thrombin in the initiation of the immune response to therapeutic factor VIII.

Authors: Jonathan Skupsky; Ai-Hong Zhang; Yan Su; David W Scott
Journal: Blood Date: 2009-09-30 Impact factor: 22.113

Review 6. Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.

Authors: Ai Hong Zhang; Jonathan Skupsky; David W Scott
Journal: Clin Rev Allergy Immunol Date: 2009-10 Impact factor: 8.667

6 in total